Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

If you’re substantially overweight and you’re relying on willpower and effort to lose the weight, the odds are very high that ...

At the core of every AI coding agent is a technology called a large language model (LLM), which is a type of neural network ...

How do caterpillars keep memories after dissolving into soup? How do we transform without fragmenting? A new AI architecture ...

If you’re a salaried employee, the new labour codes that kicked in on November 21 are likely to reshape the way your salary looks — and even how much you take home each month. While these codes don’t ...

The move undoes the Biden administration’s update to using Calibri in official department documents in 2023 amid a movement to make webpages and publications more accessible. Then-Secretary of State ...

(WJET/WFXP)– The City of Erie’s Redevelopment Authority announced a new program giving homeowners some financial help with demolishing old, blighted structures like detached garages on their property.

Nearly a third of US teenagers say they use AI chatbots daily, a new study finds, shedding light on how young people are embracing a technology that’s raised critical safety concerns around mental ...